跳至主要内容
临床试验/NCT00540956
NCT00540956已完成不适用

Descriptive Study Evaluating the Presence and Function of Natural Killer Cells in Elderly Patients With Acute Myeloid Leukemia in First Remission.

Institut Paoli-Calmettes2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2006年11月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Evolution of functional natural killer (NK) cells after chemotherapy

研究概览

简要总结

RATIONALE: Studying natural killer cells in samples of blood from patients with cancer may help doctors find out how these cells are effected by chemotherapy.

PURPOSE: This clinical trial is studying natural killer cells in older patients with acute myeloid leukemia.

详细描述

OBJECTIVES:

Primary

  • Determine the evolution of functional receptors of natural killer (NK) cells after completion of chemotherapy in elderly patients with acute myeloid leukemia in first remission.

Secondary

  • Measure the kinetics of cytotoxic functional recovery of NK cells.
  • Determine activation markers of NK cells.

研究设计

研究类型
Interventional
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • DISEASE CHARACTERISTICS:
  • Diagnosis of acute myeloid leukemia
  • No promyelocytic leukemia
  • No prior therapy
  • PATIENT CHARACTERISTICS:
  • Hemoglobin > 10 g/dL
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics

排除标准

  • 未提供

结局指标

主要结局

Evolution of functional natural killer (NK) cells after chemotherapy

次要结局

  • Kinetics of NK cells
  • Activation markers of NK cells

研究者

发起方
Institut Paoli-Calmettes
申办方类型
Other

研究点 (2)

Loading locations...

相似试验